This stock will recover and it's simply too cheap sitting around a$32 m market cap.
It's got a lot more going for it than the majority of other med device stocks in the ASX.
It's clear the market has oversold it
The board are paying more in the last cr than you can buy in market
That's clear the market has oversold it.
Our adapt product and it's eever growing portfolio of applications is a market leader and gaining more and more market penetration with the right sales people.
Add to this we have the adapt tissue being applied to a tavr device of our own investment which is in talks to partner with a major
Only a major can take this forward. Not some small fry.
The options are trading at 0.107 cents and when this is the case it's only a matter of time the heads start to move up back where they should be.
It's only a matter of sentiment and momentum now.
Too cheap
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |